Patents by Inventor Mireia Pastó Aguilà

Mireia Pastó Aguilà has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190002407
    Abstract: Object of the present invention is an improved process for the preparation of (3R,4R)-1-benzyl-4-methylpiperidin-3-amine by means of chiral Rhodium catalysts.
    Type: Application
    Filed: June 25, 2018
    Publication date: January 3, 2019
    Applicant: F.I.S. - Fabbrica Italiana Sintetici S.p.A.
    Inventors: Mireia Pastó Aguilà, Sara Preciado Gallego, Emanuele Miserazzi
  • Publication number: 20150152114
    Abstract: A process for the preparation of 4,6-dihalopyrimidin-5-amines of formula (II), or salts thereof, which comprises reacting 5-aminopyrimidin-4,6-diols of formula (III), or salts thereof, or a solvate either of the compound of formula (III) or of a salt thereof, with a halogenating agent, new intermediates useful in the preparation of the compound of formula (II) and processes for the preparation of these intermediates. The invention also refers to a process for the preparation of ticagrelor or a pharmaceutically acceptable salt thereof from 4,6-dihalo-2-(propylthio)pyrimidin-5-amine of formula (IIA).
    Type: Application
    Filed: August 5, 2013
    Publication date: June 4, 2015
    Applicant: ENANTIA, S.L.
    Inventors: Mireia Pastó Aguilá, Alexander Christian Comely
  • Patent number: 8981105
    Abstract: A process of preparation of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 and R2 represent H; or either R1 represents ethyl and R2 represents n-hexyloxycarbonyl that applies to industrial scale, novel intermediates useful for the preparation thereof, and processes of preparing said intermediates.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: March 17, 2015
    Assignee: Esteve Quimica, S.A.
    Inventors: Antoni Segade Rodríguez, Mireia Pastó Aguilá
  • Publication number: 20130116440
    Abstract: A process of preparation of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 and R2 represent H; or either R1 represents ethyl and R2 represents n-hexyloxycarbonyl that applies to industrial scale, novel intermediates useful for the preparation thereof, and processes of preparing said intermediates.
    Type: Application
    Filed: July 8, 2011
    Publication date: May 9, 2013
    Applicant: ESTEVE QUÁMICA, S.A.
    Inventors: Antoni Segade Rodríguez, Mireia Pastó Aguilá
  • Publication number: 20130116441
    Abstract: Process for the preparation of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 and R2 represent H; or either R1 represents ethyl and R2 represents n-hexyloxycarbonyl that applies to industrial scale, novel intermediates useful for the preparation thereof, and processes of preparing said intermediates.
    Type: Application
    Filed: July 8, 2011
    Publication date: May 9, 2013
    Applicant: ESTEVE QUIMICA, S.A.
    Inventors: Antoni Segade Rodríguez, Mireia Pastó Aguilà
  • Publication number: 20120283434
    Abstract: A process for the preparation of rivaroxaban, or a pharmaceutically acceptable salt thereof, or a solvate thereof, including a hydrate, comprising submitting an amine compound of formula (III) wherein R1 is a (C4-C10)-alkyl radical which is attached to the N atom by a tertiary C atom, first to an acylation reaction and then to a dealkylation reaction.
    Type: Application
    Filed: January 3, 2011
    Publication date: November 8, 2012
    Applicant: ENANTIA, S.L.
    Inventors: Llorenç Rafecas Jané, Alexander Christian Comely, Alessandro Ferrali, Celia Amela Cortés, Mireia Pastó Aguilà
  • Publication number: 20090099367
    Abstract: Process for preparing montelukast or a pharmaceutically acceptable salt thereof, especially its sodium salt, that comprises the condensation of an aldehyde and 7-chloro-2-methylquinoline. Moreover, novel intermediates useful for the synthesis of montelukast are described as well as their preparation.
    Type: Application
    Filed: March 5, 2007
    Publication date: April 16, 2009
    Applicant: FARMAPROJECTS, S. A.
    Inventors: Jordi Bessa Bellmunt, Llorenc Rafecas Jane, Mireia Pasto Aguila, Xavier Verdaguer Espaulella, Esther Gordo Campon